MAR 21, 2019 7:00 AM PDT

Phenotyping the tumor micro-environment with advanced tissue-based multiplexing assays

Sponsored by: Ultivue
Speaker
  • Senior Field Applications Scientist, Ultivue
    Biography
      Dr. Patel is a Senior Field Applications Scientist at Ultivue. Prior to joining Utivue, Dr. Patel was a Product Manager at PerkinElmer for the Quantitative Pathology Solutions group where he managed their multiplex IHC portfolio. He has extensive experience developing reagent-driven solutions for high-definition biological imaging in situ, combining high-level multiplexing at high speed with high spatial resolution, specifically in the field of immuno-oncology. Over the course of his career, Dr. Patel has worked with a variety of proprietary reagents, whole-slide imaging instruments, and bioinformatics tools. He earned his PhD from the University of Massachusetts, Amherst in Microbiology, focusing on Infectious Diseases & Immunology

    Abstract
    DATE:  March 21, 2019
    TIME:  7:00am PDT, 10:00am EDT
     
    The benefits of multiplex immunohistochemistry assays for tissue analysis are numerous. High-level multiplexing, whole slide imaging, workflow compatibility, and spatial analysis are all must-have requirements for effective multiplex IHC solutions. This webinar will provide insight into how Ultivue’s InSituPlex® technology addresses each of these needs and current challenges to enable researchers to unmask the true biology of tissue samples.
     
    Learning Objectives:
    • Better understand the complexity of the tumor microenvironment (TME)
    • Introduction to InSituPlex® DNA-barcoding and antibody staining technology for multiplex fluorescence IHC
    • How to make use of multi-parameter data within the TME - spatial mapping, high and low expression, and co-localization of markers on individual cells

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    MAR 21, 2019 7:00 AM PDT

    Phenotyping the tumor micro-environment with advanced tissue-based multiplexing assays

    Sponsored by: Ultivue

    Specialty

    Cancer Research

    Immunology

    Molecular Biology

    Cell Biology

    Biomarkers

    Cancer Therapeutics

    Cancer Diagnostics

    Biotechnology

    Molecular Diagnostics

    Oncology

    Genetics

    Clinical Research

    Cell Culture

    Drug Discovery

    Clinical Diagnostics

    Geography

    North America57%

    Europe23%

    Asia12%

    South America3%

    Africa3%

    Oceania1%

    Registration Source

    Email Promotions56%

    Website Visitors36%

    WAVE Newsletter Promotion5%

    Trending Newsletter Promotion1%

    Other2%

    Job Title

    Research Scientist17%

    Student13%

    Scientist13%

    Executive11%

    Educator/Faculty10%

    Facility/Department Manager9%

    Medical Laboratory Technician9%

    Medical Doctor/Specialist5%

    Post Doc5%

    Lab Management3%

    Clinical Laboratory Scientist2%

    Pathologist1%

    Consultant1%

    Organization

    Academic Institution25%

    Biotech Company13%

    Research Institute10%

    Hospital10%

    Pharmaceutical Company6%

    Clinical Laboratory5%

    Government4%

    Life Science Company4%

    Medical School3%

    Medical Center3%

    Non-Profit Organization2%

    Contract Research Organization (Cro)2%

    Consultant1%

    Industrial Company1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more